LYN has also been identified as an important driver of phospho-tyrosine signalling to induce invasiveness within basal subtype breast cancers, although that study reported a relatively low level of activated LYN within the MDA-MB-468 cell line [67]. The gene discussed is LYN; the disease is breast carcinoma.